Antibodies to CD200R

Details for Australian Patent Application No. 2007338670 (hide)

International Classifications

Event Publications

16 July 2009 PCT application entered the National Phase

PCT publication WO2008/079352 Priority application(s): WO2008/079352

1 October 2009 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 03 Aug 2009

12 November 2009 Section 223 Application Received

SCHERING CORPORATION An application to extend the time from 02 Jul 2008 to 03 Oct 2009 in which to comply with section 6(c) has been filed . Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 Extensions of Time, Section 223

7 January 2010 Section 223 Application Allowed

SCHERING CORPORATION The time in which to comply with section 6(c) has been extended to 03 Oct 2009. Address for service in Australia - Griffith Hack Level 29, Northpoint 100 Miller Street North Sydney NSW 2060 2009

4 October 2012 Alteration of Name

The name of the applicant has been altered to Merck Sharp & Dohme Corp.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.